Result Summaries: darotropium bromide
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 112016 | Phase 1 | Phase I study of GSK233705 - A randomised, double blind, placebo-controlled, 2-parts study to investigate the safety, tolerability, and pharmacokinetics of single and repeat inhaled doses of GSK233705 from a novel dry powder device in healthy Japanese male subjects - (0 citation(s)) |  |